As Alzheimer's Studies Progress, Debate On Cause Persists

Sidebar: Genetics of Alzheimer's Disease -- Further Information At its annual meeting in November 1995, the Society for Neuroscience hosted a lively debate on whether ß-amyloid deposition is the cause of Alzheimer's disease. The debate was light in tone, but that masked real and often rancorous divisions in the field (R. Finn, The Scientist, Oct. 16, 1995, page 14.). Since then, significant advances in this rapidly developing discipline have generated considerable excitement among Alzheim

Written byRobert Finn
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Sidebar: Genetics of Alzheimer's Disease -- Further Information

Back in 1907, Alois Alzheimer first noticed the two main neuropathological hallmarks of the disease-amyloid plaques and neurofibrillary tangles-in the brain tissue of a 51-year-old demented woman. The idea that abnormal deposition of ß-amyloid (also called Ab) was the primary cause was given considerable weight by the 1991 discovery that a rare inherited form of early-onset Alzheimer's disease was caused by a mutant form of the gene encoding amyloid precursor protein (APP), which is found on chromosome 21.

UNCONVINCED: Warren Strittmatter is skeptical that presenilin mutations work through an amyloid-related mechanism. But others focused on mechanisms involving neurofibrillary tangles, especially after the 1993 discovery of the role of apolipoprotein E (apoE) in Alzheimer's. There are three main alleles of apoE-E2, E3, and E4. Warren J. Strittmatter, Allen Roses, and their colleagues at Duke University Medical Center determined that individuals who inherit one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies